Myrbetriq and Bladder dysfunction - a phase IV clinical study of FDA data

Summary:

Bladder dysfunction is reported as a side effect among people who take Myrbetriq (mirabegron), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Cymbalta, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Bladder dysfunction when taking Myrbetriq. It is created by eHealthMe based on reports of 33,382 people who have side effects when taking Myrbetriq from the FDA, and is updated regularly.

What is Myrbetriq?

Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 33,658 Myrbetriq users. Check the latest studies of Myrbetriq.

What is Bladder dysfunction?

Bladder dysfunction is found to be associated with 229 drugs and 275 conditions by eHealthMe. Check the latest studies of Bladder dysfunction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

33,382 people reported to have side effects when taking Myrbetriq.
Among them, 23 people (0.07%) have Bladder dysfunction.

Could Myrbetriq cause Bladder dysfunction?

Among these 23 people:

How long have people been on Myrbetriq when they have Bladder dysfunction? *

What is the gender of people who have Bladder dysfunction when taking Myrbetriq? *

female: 86.96 %
male: 13.04 %

What is the age of people who have Bladder dysfunction when taking Myrbetriq? *

What are other drugs people take besides Myrbetriq? *

What are other side effects people have besides Bladder dysfunction? *

Weakness: 19 people, 82.61%
Fatigue (feeling of tiredness): 18 people, 78.26%
Balance Disorder: 11 people, 47.83%
Pneumonia: 11 people, 47.83%
Back Pain: 11 people, 47.83%
Urinary Tract Infection: 10 people, 43.48%
Drowsiness: 10 people, 43.48%
Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 43.48%
Pain: 10 people, 43.48%
Pain In Extremity: 9 people, 39.13%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 56.52%
Gait Disturbance: 8 people, 34.78%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 26.09%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 5 people, 21.74%
Sleep Apnea Syndrome: 4 people, 17.39%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 17.39%
Dermatosis (a disease of the skin, esp. one that does not cause inflammation): 4 people, 17.39%
Constipation: 4 people, 17.39%
Oedema Peripheral (superficial swelling): 3 people, 13.04%
Drowsiness: 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Myrbetriq and have Bladder dysfunction?

- Check whether Bladder dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Myrbetriq:

Myrbetriq (33,658 reports)

Browse all side effects of Myrbetriq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bladder dysfunction:

Bladder dysfunction (229 drugs)

Browse all the conditions that are associated with Bladder dysfunction:

Bladder dysfunction (275 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron (the active ingredients of Myrbetriq) and Myrbetriq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.